Trinity Biotech (TRIB) Temporarily Suspends FDA Trials for Meritas Troponin Test
Tweet Send to a Friend
Trinity Biotech plc (Nasdaq: TRIB) today announced results for the quarter ended September 30, 2014. In addition, it announced that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE